Evidence map›Paper›PMID 17360672›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia.

Georges M G M Verjans, Rogier Q Hintzen, Jessica M van Dun, Angelique Poot, Johannes C Milikan, Jon D Laman, Anton W Langerak, Paul R Kinchington, Albert D M E Osterhaus

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 233 citations in OpenAlex.

  1. Trial
  2. Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  3. Varicella zoster virus and the central nervous system.Nature reviews. Microbiology · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Unraveling the complexities of neurotropic virus infection and immune evasion.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  8. Review
  9. Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. CD8Immunity · 2023
    Review
  15. Article
  16. Review
  17. Immune Responses to Varicella-Zoster Virus Vaccines.Current topics in microbiology and immunology · 2023
    Article
  18. Article
  19. Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Georges M G M VerjansDepartment of Virology, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands. g.verjans@erasmusmc.nl
Rogier Q Hintzen
Jessica M van Dun
Angelique Poot
Johannes C Milikan
Jon D Laman
Anton W Langerak
Paul R Kinchington
Albert D M E Osterhaus
Rotterdam Eye Hospital · NLNeurology, Inc · USUniversity of Pittsburgh · US

Funding

Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ethan A Rossi · 1989 to 2026
$17.8M
Gene Expression in HSV-1 Latency After Corneal InfectionR01EY015291 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KINCHINGTON, PAUL R. · 2004 to 2013
$2.9M
VARICELLA ZOSTER VIRUS REGULATORY PROTEINSR01EY009397 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KINCHINGTON, PAUL R. · 1992 to 2005
$2.2M
NEI NIH HHS EY08098NEI NIH HHS EY09397NEI NIH HHS EY15291NEI NIH HHS P30 EY008098NEI NIH HHS R01 EY009397NEI NIH HHS R01 EY015291
6 · The paper itself

Abstract

Primary infection with herpes simplex virus 1 (HSV-1) and varicella zoster virus (VZV) results in lifelong latent infections of neurons in sensory ganglia such as the trigeminal ganglia (TG). It has been postulated that T cells retained in TG inhibit reactivation of latent virus. The acquisition of TG specimens of individuals within hours after death offered the unique opportunity to characterize the phenotype and specificity of TG-resident T cells in humans. High numbers of activated CD8(+) T cells expressing a late effector memory phenotype were found to reside in latently infected TG. The T cell infiltrate was oligoclonal, and T cells selectively clustered around HSV-1 but not VZV latently infected neurons. Neuronal damage was not observed despite granzyme B expression by the neuron-interacting CD8(+) T cells. The TG-resident T cells, mainly CD8(+) T cells, were directed against HSV-1 and not to VZV, despite neuronal expression of VZV proteins. The results implicate that herpesvirus latency in human TG is associated with a local, persistent T cell response, comprising activated late effector memory CD8(+) T cells that appear to control HSV-1 latency by noncytolytic pathways. In contrast, T cells do not seem to be directly involved in controlling VZV latency in human TG.

Indexed as

Herpesvirus 1, HumanHerpesvirus 3, HumanAntibodies, MonoclonalCD8-Positive T-LymphocytesGranzymesHerpesviridae InfectionsHumansImmunoenzyme TechniquesTrigeminal GanglionVirus LatencyAntibodies, MonoclonalGranzymes

Identifiers

PMID17360672
PMCPMC1805572
OpenAlexW1986868882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.